XML 104 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Goodwill and Intangible Assets (Notes)
12 Months Ended
Dec. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets
GOODWILL AND INTANGIBLE ASSETS
Definite Lived Intangible Assets

(Dollars in thousands)
December 31, 2013
 
December 31, 2012
 
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
 
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
Trademarks and patents
$
1,075

 
$
303

 
$
772

 
$
1,066

 
$
227

 
$
839

Technology
37,825

 
13,340

 
$
24,485

 
36,479

 
8,394

 
28,085

Covenant-not-to-compete
1,056

 
628

 
$
428

 
1,042

 
358

 
684

Customer relationships
21,280

 
3,235

 
$
18,045

 
20,529

 
2,066

 
18,463

Total other intangible assets
$
61,236

 
$
17,506

 
$
43,730

 
$
59,116

 
$
11,045

 
$
48,071


In the table above, gross carrying amounts and accumulated amortization may differ from prior periods due to foreign exchange rate fluctuations.
Amortization expense was approximately $6.0 million, $4.4 million and $5.4 million in 2013, 2012 and 2011, respectively.  The estimated annual future amortization expense is $5.9 million, $5.5 million, $5.0 million and $4.4 million in 2014, 2015, 2016 and 2017, respectively.  These amounts could vary based on changes in foreign currency exchange rates.
The weighted average amortization period as of December 31, 2013, by intangible asset class, is presented in the table below:

Intangible Asset Class
 
Weighted Average Amortization Period
Trademarks and patents
 
6.9
Technology
 
4.0
Covenant not-to-compete
 
1.5
Customer relationships
 
6.9
Total other intangible assets
 
5.2

On January 4, 2011 we acquired Curamik, a manufacturer of power electronic substrate products, which contributed $52.4 million of intangible assets and $79.8 million of goodwill.  The intangible assets are comprised of trademarks, technology, and customer relationships and include approximately $5.3 million of indefinite-lived intangible assets comprised of trademarks, which are assessed for impairment annually or when changes in circumstances indicate that the carrying values may not be recoverable.  The definite-lived intangible assets are amortized using a fair value methodology that is based on the projected economic use of the related underlying asset.
Goodwill
The changes in the carrying amount of goodwill for the period ending December 31, 2013, by reportable segment, are as follows:

(Dollars in thousands)
High Performance Foams
 
Printed Circuit Materials
 
Power Electronics Solutions
 
Other
 
Total
December 31, 2012
$
23,973

 
$

 
$
78,844

 
$
2,224

 
$
105,041

Foreign currency translation adjustment
232

 

 
3,398

 

 
3,630

December 31, 2013
$
24,205

 
$

 
$
82,242

 
$
2,224

 
$
108,671



Annual Impairment Testing

We perform our annual goodwill impairment testing in the fourth quarter of the year. In 2013, we estimated the fair value of our reporting units using an income approach based on the present value of future cash flows. We believe this approach yields the most appropriate evidence of fair value as our reporting units are not easily compared to other corporations involved in similar businesses. We further believe that the assumptions and rates used in our annual impairment test are reasonable, but inherently uncertain. We currently have three reporting units with goodwill and intangible assets - High Performance Foams, Curamik and the Elastomer Components Division (ECD). The HPF, Curamik and ECD reporting units had allocated goodwill of approximately $24.2 million, $82.2 million and $2.2 million, respectively, at December 31, 2013. No impairment charges resulted from these analyses. The excess of fair value over carrying value for these reporting units was 405% for HPF, 30% for Curamik and 200% for ECD. From a sensitivity perspective, if the fair value of these reporting units declined by 10%, the fair value of the HPF reporting unit would exceed its carrying value by approximately 355%, the fair value of the Curamik reporting unit would exceed its carrying value by approximately 17%, and the fair value of the ECD reporting unit would exceed its carrying value by approximately 170%. These valuations are based on a five year discounted cash flow analysis, which utilized a discount rates ranging from 13.0% for HPF and ECD to 14.5% for Curamik and a terminal year growth rate of 3% for all three reporting units.